Changes to the website
Sponsored By
Monteris Laser Therapy For Brain Tumors
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4898

Next 25
Website Changes
12/01/2016 New edition of the "Brain Tumor Guide for the Newly Diagnosed"
11/30/2016 Israel firm has high hopes for new cancer-busting drug
11/26/2016 SNO 2016 Clinical Highlights
11/26/2016 PCV chemotherapy
11/26/2016 Society for Neuro Oncology annual meeting, Scottsdale Arizona, November 17-20 2016
11/25/2016 Clinical and Pre-Clinical Data on Mustang Bio’s MB-101 (IL13Ra2-specific CAR T cells) for the Treatment of Glioblastoma (GBM) Presented at the 21st Annual Meeting and Education Day of the Society for Neuro-Oncology
11/25/2016 ZIOPHARM Announces Clinical Data on Ad-RTS-hIL-12 Demonstrates Survival Benefits in Patients with Recurrent Brain Cancer
11/24/2016 Dr. Reardon on the KEYNOTE-028 Trial of Pembrolizumab for GBM
11/23/2016 Help Us Better Understand Glioblastoma Multiforme (GBM) Patient Experiences
11/21/2016 Society of Neuro-Oncology Annual Meeting Abstract Now Available Online!
11/21/2016 ImmunoCellular Therapeutics (IMUC) Announces Presentation of Updated ICT-107 Phase 2 Data in GBM
11/21/2016 Tocagen Presents Updated Clinical and Preclinical Data at Scientific Meetings
11/18/2016 Long-Term Analysis of All 695 Patients Enrolled in Novocure’s Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results and Demonstrates Superior Two- and Four-Year Survival Rates
11/09/2016 DNAtrix Announces First Patients Treated in Phase 2 Trial with DNX-2401 and KEYTRUDA
11/09/2016 Musella Foundation Co-payment Assistance Program is now closed to new patients
11/09/2016 New vaccine for brain cancer brings hope to those fighting the disease
11/08/2016 Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers.
11/07/2016 Novocure Announces 38 Presentations on Tumor Treating Fields at 21st Annual Scientific Meeting of the Society of Neuro-Oncology
11/07/2016 United Healthcare Issues Positive Coverage Decision for Optune
10/25/2016 Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature.
10/23/2016 The Musella Foundation announced that it has awarded a $25,000 brain tumor research grant to Dr. Robert Prins of UCLA.
10/22/2016 Patient-Tailored Immunotherapy Shows Promise in Treating Brain Cancer
10/20/2016 An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.
10/09/2016 High response rate in phase I/II paediatric brain cancer trial
10/09/2016 Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites